The significance of the 4Kscore in predicting medium- to long-term prostate cancer risk: insights from the European prospective investigation into cancer and nutrition
Translational Cancer Research · 2026-07 · 15 (7) · 515-515
DOI: 10.21037/tcr-2026-0664 ↗Kurz gefasst
Editorial in der Zeitschrift Translational Cancer Research, 2026-07. Verfasst von Yozo Mitsui und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Toho University Faculty of Medicine, Tokyo, Japan. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
, along with clinical variables including age, history of negative biopsy, and digital rectal examination (DRE) findings. The NCCN guidelines recommend use of the 4Kscore both before the initial biopsy and after an initial negative biopsy. This recommendation is supported by results obtained in various studies, including a meta-analysis of USA and European cohorts (3), which demonstrated that the 4Kscore is a valid and clinically valuable biomarker for detection of high-grade PC. By addressing the limited specificity of PSA alone, the 4Kscore is considered to
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Toho University Faculty of Medicine, Tokyo, Japan.
ORCID-Profile: Yozo Mitsui
Zitieren
APA
Mitsui, Y., & Nakajima, K. (2026). The significance of the 4Kscore in predicting medium- to long-term prostate cancer risk: insights from the European prospective investigation into cancer and nutrition. Translational Cancer Research, 15(7), 515-515. https://doi.org/10.21037/tcr-2026-0664
Vancouver
Mitsui Y, Nakajima K. The significance of the 4Kscore in predicting medium- to long-term prostate cancer risk: insights from the European prospective investigation into cancer and nutrition. Translational Cancer Research. 2026;15(7):515-515. doi:10.21037/tcr-2026-0664
BibTeX
@article{Mitsui2026,
author = {Mitsui, Yozo and Nakajima, Koichi},
title = {The significance of the 4Kscore in predicting medium- to long-term prostate cancer risk: insights from the European prospective investigation into cancer and nutrition},
journal = {Translational Cancer Research},
year = {2026},
volume = {15},
number = {7},
pages = {515--515},
doi = {10.21037/tcr-2026-0664}
}
EUVIMED